NEW YORK (GenomeWeb News) – Roche today said that the US Food and Drug Administration approved a new workflow process for the company's Cobas HPV test.

The newly approved workflow option allows for a sample to be processed from the primary sample collection vial directly after it has been used for cytology testing. This allows laboratories to load the same vial used for a ThinPrep Pap test onto the Cobas 4800 system for high-risk human papillomavirus and individual HPV 16 and HPV 18 genotype testing, Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.